↓ Skip to main content

Dove Medical Press

β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways

Overview of attention for article published in OncoTargets and therapy, June 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
22 Mendeley
Title
β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways
Published in
OncoTargets and therapy, June 2020
DOI 10.2147/ott.s242820
Pubmed ID
Authors

Pengyu Su, Bashir Ahmad, Kun Zou, Lijuan Zou

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 18%
Student > Ph. D. Student 4 18%
Unspecified 1 5%
Student > Postgraduate 1 5%
Student > Bachelor 1 5%
Other 0 0%
Unknown 11 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 18%
Chemistry 2 9%
Biochemistry, Genetics and Molecular Biology 2 9%
Medicine and Dentistry 2 9%
Unspecified 1 5%
Other 1 5%
Unknown 10 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2020.
All research outputs
#17,297,846
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#1,149
of 3,016 outputs
Outputs of similar age
#279,059
of 433,033 outputs
Outputs of similar age from OncoTargets and therapy
#31
of 113 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,033 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.